Literature DB >> 24226270

Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center.

Alberto Serrano-Pozo1, Jing Qian, Sarah E Monsell, Matthew P Frosch, Rebecca A Betensky, Bradley T Hyman.   

Abstract

To test the hypothesis that Alzheimer disease (AD) is a clinical and pathologic continuum between normal aging and end-stage dementia, we selected a convenience sample of subjects from the National Alzheimer Coordinating Center 2005 to 2012 autopsy cohort (n = 2,083) with the last clinical evaluation within 2 years before autopsy and no other primary neuropathologic diagnosis. Demographic and neuropathologic characteristics were correlated with the Clinical Dementia Rating-Sum of Boxes in the 835 subjects meeting these criteria. Both neuritic plaques and neurofibrillary tangles independently predicted Clinical Dementia Rating-Sum of Boxes. Severe small-vessel disease, severe amyloid angiopathy, and hippocampal sclerosis were also independently associated with the degree of cognitive impairment. By contrast, education was a strong independent protective factor against cognitive deficits. The cause of mild to moderate dementia remained uncertain in 14% of the patients. Inverse probability weighting suggests the generalizability of these results to nonautopsied cohorts. These data indicate that plaques and tangles independently contribute to cognitive impairment, that concurrent vascular disease strongly correlates with cognitive dysfunction even in a sample selected to represent the AD pathologic continuum, and that education further modifies clinical expression. Thus, multiple concomitant etiologies of brain damage and premorbid characteristics contribute to the uncertainty of AD clinicopathologic correlations based only on tangles and plaques.

Entities:  

Mesh:

Year:  2013        PMID: 24226270      PMCID: PMC3962953          DOI: 10.1097/NEN.0000000000000016

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  85 in total

Review 1.  Education and the prevalence of dementia and Alzheimer's disease.

Authors:  R Katzman
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

2.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

3.  Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.

Authors:  T Gómez-Isla; R Hollister; H West; S Mui; J H Growdon; R C Petersen; J E Parisi; B T Hyman
Journal:  Ann Neurol       Date:  1997-01       Impact factor: 10.422

4.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease.

Authors:  P V Arriagada; J H Growdon; E T Hedley-Whyte; B T Hyman
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

5.  The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution.

Authors:  B T Hyman; K Marzloff; P V Arriagada
Journal:  J Neuropathol Exp Neurol       Date:  1993-11       Impact factor: 3.685

Review 6.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease.

Authors:  P V Arriagada; K Marzloff; B T Hyman
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

8.  Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans.

Authors:  D W Dickson; P Davies; C Bevona; K H Van Hoeven; S M Factor; E Grober; M K Aronson; H A Crystal
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.

Authors:  L M Bierer; P R Hof; D P Purohit; L Carlin; J Schmeidler; K L Davis; D P Perl
Journal:  Arch Neurol       Date:  1995-01

10.  Early association of reactive astrocytes with senile plaques in Alzheimer's disease.

Authors:  C J Pike; B J Cummings; C W Cotman
Journal:  Exp Neurol       Date:  1995-04       Impact factor: 5.330

View more
  58 in total

1.  Ultrasound attacks Alzheimer's disease?

Authors:  Shuko Takeda; Ryuichi Morishita
Journal:  Ann Transl Med       Date:  2015-10

2.  Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients.

Authors:  Shuko Takeda; Caitlin Commins; Sarah L DeVos; Chloe K Nobuhara; Susanne Wegmann; Allyson D Roe; Isabel Costantino; Zhanyun Fan; Samantha B Nicholls; Alexis E Sherman; Ana T Trisini Lipsanopoulos; Clemens R Scherzer; George A Carlson; Rose Pitstick; Elaine R Peskind; Murray A Raskind; Ge Li; Thomas J Montine; Matthew P Frosch; Bradley T Hyman
Journal:  Ann Neurol       Date:  2016-08-03       Impact factor: 10.422

3.  Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability.

Authors:  Georgette L Suidan; Pradeep K Singh; Sunita Patel-Hett; Zu-Lin Chen; Dmitri Volfson; Hitomi Yamamoto-Imoto; Erin H Norris; Robert D Bell; Sidney Strickland
Journal:  Blood Adv       Date:  2018-05-08

Review 4.  Is Alzheimer's Disease Risk Modifiable?

Authors:  Alberto Serrano-Pozo; John H Growdon
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 5.  Interactions of β-amyloid peptide with fibrinogen and coagulation factor XII may contribute to Alzheimer's disease.

Authors:  Hyung J Ahn; Zu-Lin Chen; Daria Zamolodchikov; Erin H Norris; Sidney Strickland
Journal:  Curr Opin Hematol       Date:  2017-09       Impact factor: 3.284

6.  Alzheimer's disease neuropathology may not predict functional impairment in HIV: a report of two individuals.

Authors:  Susan Morgello; Michelle Jacobs; Jacinta Murray; Desiree Byrd; Eric Neibart; Letty Mintz; Gregory Meloni; Christina Chon; John Crary
Journal:  J Neurovirol       Date:  2018-08-09       Impact factor: 2.643

7.  Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum.

Authors:  Alberto Serrano-Pozo; Jing Qian; Alona Muzikansky; Sarah E Monsell; Thomas J Montine; Matthew P Frosch; Rebecca A Betensky; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2016-04-22       Impact factor: 3.685

Review 8.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

9.  Aminopyrimidine Class Aggregation Inhibitor Effectively Blocks Aβ-Fibrinogen Interaction and Aβ-Induced Contact System Activation.

Authors:  Pradeep K Singh; Masanori Kawasaki; Hanna E Berk-Rauch; Goushi Nishida; Takeshi Yamasaki; Michael A Foley; Erin H Norris; Sidney Strickland; Kazuyoshi Aso; Hyung Jin Ahn
Journal:  Biochemistry       Date:  2018-02-09       Impact factor: 3.162

Review 10.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.